NOV (NOV) analyst forecast and price target
Analyst forecast
Consensus of 22 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Underweight | $20.00 from $21.00 | Jul 31, 2026 |
| TD Cowen | Maintained | Buy | $26.00 from $25.00 | Jul 30, 2026 |
| Susquehanna | Maintained | Positive | $24.00 from $22.00 | Jul 30, 2026 |
| Susquehanna | Maintained | Positive | $22.00 from $24.00 | Jul 8, 2026 |
| Citigroup | Maintained | Neutral | $22.00 from $20.00 | Jun 18, 2026 |
| Barclays | Downgraded | Equal-Weight → Underweight | $21.00 from $20.00 | May 8, 2026 |
| Susquehanna | Maintained | Positive | $24.00 from $22.00 | Apr 29, 2026 |
| Evercore ISI Group | Maintained | In-Line | $22.00 from $19.00 | Apr 29, 2026 |
| RBC Capital | Maintained | Sector Perform | $22.00 from $21.00 | Apr 29, 2026 |
| Stifel | Maintained | Buy | $23.00 from $21.00 | Apr 20, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $20.00 from $18.00 | Apr 15, 2026 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $21.00 | Apr 14, 2026 |
| Susquehanna | Maintained | Positive | $22.00 from $21.00 | Apr 7, 2026 |
| Goldman Sachs | Maintained | Sell | $20.00 from $17.00 | Mar 4, 2026 |
| Citigroup | Maintained | Neutral | $20.00 from $17.00 | Feb 11, 2026 |
| Piper Sandler | Maintained | Neutral | $18.00 from $17.00 | Feb 9, 2026 |
| BMO Capital | Maintained | Market Perform | $20.00 from $19.00 | Feb 9, 2026 |
| Stifel | Maintained | Buy | $21.00 from $19.00 | Feb 6, 2026 |
| Barclays | Upgraded | Underweight → Equal-Weight | $20.00 from $15.00 | Feb 4, 2026 |
| Susquehanna | Maintained | Positive | $20.00 from $17.00 | Jan 7, 2026 |
Frequently asked questions
What is the price target for NOV stock?
The average 12-month analyst price target for NOV (NOV) is $23.00, with a high estimate of $26.00 and a low of $20.00, across 4 analysts.
Is NOV a buy, sell, or hold?
Analysts covering NOV currently average a Hold rating: 7 buy, 13 hold and 2 sell, from 22 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for NOV?
The average price target of $23.00 implies 8.85% upside from the last price of $21.13.
What is the latest analyst rating on NOV?
On Jul 31, 2026, Barclays maintained NOV at Underweight with a price target of $20.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.